Kristine Mørch
Stilling
Førsteamanuensis, Leder nasjonalt senter for tropiske infeksjonssykdommer, infeksjonsseksjonen, medisinsk avdeling, Haukeland universitetssykehus
Tilhørighet
Forskning
Kristine Mørch, MD, PhD er leder ved Nationalt senter for tropiske infeksjonssykdommer ved infeksjonsseksjonen, medisinsk avdeling, Haukeland universitetssykehus. Hun er også førsteamanuensis ved klinisk institutt ved Universitetet i Bergen. Hennes forskningsinteresser er innenfor tropiske infeksjonssykdommer, spesielt akutt febersykdom og malaria, samt Giardia infeksjon med fokus på metronidazolresistens og behandling.
Publikasjoner
Vitenskapelig artikkel
- Hoem, Eli Leirdal; Kvalvik, Torleiv; Dyrhovden, Ruben et al. (2024). En kvinne i 70-årenemed feber og krampeanfall. (ekstern lenke)
- Blomberg, Bjørn; Bruun, Trond; Jordal, Stina et al. (2024). Ein mann i 60-åra med livstrugande febersjukdom etter utanlandsreise. (ekstern lenke)
- Onken, Annette; Moyo, Sabrina John; Miraji, Mohammed Khamis et al. (2024). Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar. (ekstern lenke)
- Jensenius, Mogens; Mørch, Kristine; Yakub, Sheraz et al. (2024). Alveolær ekinokokkose. (ekstern lenke)
- Mørch, Kristine; Manoharan, Anand; Chandy, Sara et al. (2023). Clinical features and risk factors for death in acute undifferentiated fever: A prospective observational study in rural community hospitals in six states of India. (ekstern lenke)
- Onken, Annette; Haanshuus, Christel Gill; Miraji, Mohammed Khamis et al. (2022). Malaria prevalence and performance of diagnostic tests among patients hospitalized with acute undifferentiated fever in Zanzibar. (ekstern lenke)
- Hanevik, Kurt; Saghaug, Christina Skår; Aaland, Maren et al. (2022). No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after Giardia infection. (ekstern lenke)
- Muller, Karl Erik; Blomberg, Bjørn; Tellevik, Marit Gjerde et al. (2021). Leishmaniasis i Norge. (ekstern lenke)
- Kristiansen, Trygve; Pettersen, Frank O.; Lier, Tore et al. (2021). Schistosomiasis hos norske studenter etter opphold i Afrika. (ekstern lenke)
- Neumayr, Andreas; Schunk, Mirjam; Theunissen, Caroline et al. (2021). Efficacy and Tolerability of Quinacrine Monotherapy and Albendazole Plus Chloroquine Combination Therapy in Nitroimidazole-Refractory Giardiasis: A TropNet Study. (ekstern lenke)
- Emberland, Knut Erik; Wensaas, Knut-Arne; Litleskare, Sverre et al. (2021). Antibiotics for gastroenteritis in general practice and out-of-hours services in Norway 2006-15. (ekstern lenke)
- Waldenström, Jesper; Hellstrand, Kristoffer; Westin, Johan et al. (2021). Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus. (ekstern lenke)
- Haanshuus, Christel Gill; Mørch, Kristine (2020). Detection of remaining Plasmodium DNA and gametocytes during follow up after curative malaria treatment among returned travellers in Norway. (ekstern lenke)
- Waldenström, Jesper; Nyström, Kristina; Nilsson, Staffan et al. (2020). The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection. (ekstern lenke)
- Moyo, Sabrina John; Manyahi, Joel; Blomberg, Bjørn et al. (2020). Bacteraemia, malaria, and case fatality among children hospitalized with fever in Dar es Salaam, Tanzania. (ekstern lenke)
- Mørch, Kristine; Hanevik, Kurt (2020). Giardiasis treatment: an update with a focus on refractory disease. (ekstern lenke)
- Blomberg, Bjørn; Muller, Karl Erik; Helgeland, Lars et al. (2019). En mann i 80-årene med leddgikt og vedvarende feber. (ekstern lenke)
- Haanshuus, Christel Gill; Mørch, Kristine; Blomberg, Bjørn et al. (2019). Assessment of malaria real-time PCR methods and application with focus on lowlevel parasitaemia. (ekstern lenke)
- Kurth, Florian; Develoux, Michel; Mechain, Matthieu et al. (2017). Severe malaria in Europe: an 8-year multi-centre observational study. (ekstern lenke)
- Mørch, Kristine; Manoharan, Anand; Chandy, Sara et al. (2017). Acute undifferentiated fever in India: A multicentre study of aetiology and diagnostic accuracy. (ekstern lenke)
- Lingscheid, Tilman; Kurth, Florian; Clerinx, Jan et al. (2017). Schistosomiasis in european travelers and migrants: Analysis of 14 years tropnet surveillance data. (ekstern lenke)
- Hanevik, Kurt; Kristoffersen, Einar Klæboe; Mørch, Kristine et al. (2017). Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome. (ekstern lenke)
- Chandy, Sara; Kirubanandhan, Lokeshwaran; Hemavathy, Priya et al. (2017). Serovar prevalence of leptospira in semirural India and the development of an igm-based indirect ELISA. (ekstern lenke)
- Wensaas, Knut-Arne; Hanevik, Kurt; Hausken, Trygve et al. (2016). Postinfectious and sporadic functional gastrointestinal disorders have different prevalences and rates of overlap: results from a controlled cohort study 3 years after acute giardiasis. (ekstern lenke)
- Waldenström, Jesper; Färkkilä, Martti A.; Rembeck, Karolina et al. (2016). Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life experience. (ekstern lenke)
- Haanshuus, Christel Gill; Chandy, Sara; Manoharan, Anand et al. (2016). A high malaria prevalence identified by PCR among patients with acute undifferentiated fever in India. (ekstern lenke)
- Heggheim, Åsmund; Blomberg, Bjørn; Mørch, Kristine (2015). Beredskap ved alvorlig malaria. (ekstern lenke)
- Ben-Chetrit, Eli; Lachish, Tamar; Mørch, Kristine et al. (2015). Schistosomiasis in pregnant travelers: A case series. (ekstern lenke)
- Kurth, Florian; Develoux, Michel; Mechain, Matthieu et al. (2015). Intravenous artesunate reduces parasite clearance time, duration of intensive care, and hospital treatment in patients with severe malaria in Europe: The TropNet severe malaria study. (ekstern lenke)
- Ydreborg, Magdalena; Lisovskaja, Vera; Lagging, Martin et al. (2014). A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. (ekstern lenke)
- Hanevik, Kurt; Wensaas, Knut-Arne; Rørtveit, Guri et al. (2014). Irritable bowel syndrome and chronic fatigue 6 years after Giardia infection: A controlled prospective cohort study. (ekstern lenke)
- Rembeck, Karolina; Waldenström, Jesper; Hellstrand, Kristoffer et al. (2014). Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3. (ekstern lenke)
- Abrahamsen, Siri Kratter; Haugen, Cathrine Ingebjørg Nødtvedt; Rupali, Priscilla et al. (2013). Fever in the tropics: aetiology and case-fatality - a prospective observational study in a tertiary care hospital in South India. (ekstern lenke)
- Haanshuus, Christel Gill; Mohn, Stein Christian; Mørch, Kristine et al. (2013). A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway. (ekstern lenke)
- Mørch, Kristine; Hanevik, Kurt; Rivenes, Ann Christin et al. (2013). Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course. (ekstern lenke)
- Alsiö, Åsa; Rembeck, Karolina; Askarieh, Galia et al. (2012). Impact of Obesity on the Bioavailability of Peginterferon-alpha 2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3. (ekstern lenke)
- Alsiö, Åsa; Jannesson, Anna-Maria; Langeland, Nina et al. (2012). Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection. (ekstern lenke)
- Hunskår, Gunnhild Sellevoll; Langeland, Nina; Wensaas, Knut-Arne et al. (2012). The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years after Giardia infection. A historic cohort study. (ekstern lenke)
- Rembeck, Karolina; Alsiö, Åsa; Christensen, Peer Brehm et al. (2012). Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and 3. (ekstern lenke)
- Hanevik, Kurt; Kristoffersen, Einar Klæboe; Sørnes, Steinar et al. (2012). Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome. (ekstern lenke)
- Rembeck, Karolina; Maglio, Cristina; Lagging, Martin et al. (2012). PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection. (ekstern lenke)
- Wensaas, Knut-Arne; Langeland, Nina; Hanevik, Kurt et al. (2012). Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. (ekstern lenke)
- Pedersen, Court; Alsiö, Åsa; Lagging, Martin et al. (2011). Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection. (ekstern lenke)
- Lindh, Maria; Eilard, Anders; Färkkilä, Martti et al. (2011). Hepatitis C treatment response kinetics and impact of baseline predictors. (ekstern lenke)
- Lindh, Magnus; Lagging, Martin; Färkkilä, Martti et al. (2011). Interleukin 28B gene variation at rs12979860 determines early viral kinetics during treatment in patients carrying genotypes 2 or 3 of hepatitis C virus. (ekstern lenke)
- Zoller, Thomas; Junghanss, Thomas; Kapaun, Annette et al. (2011). Intravenous Artesunate for Severe Malaria in Travelers, Europe. (ekstern lenke)
- Alsiö, Åsa; Christensen, Peer Brehm; Färkkilä, Martti et al. (2010). Nonresponder Patients with Hepatitis C Virus Genotype 2/3 Infection: A Question of Low Systemic Interferon Concentrations?. (ekstern lenke)
- Leutscher, Peter Derek Christian; Lagging, Martin; Buhl, Mads Rauning et al. (2010). Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. (ekstern lenke)
- Robertson, Lucy J; Hanevik, K; Escobedo, Angel A et al. (2010). Giardiasis ? why do the symptoms sometimes never stop?. (ekstern lenke)
- Escobedo, Angel A; Almirall, P; Robertson, Lucy J et al. (2010). Giardiasis: the ever-present threat of a neglected disease. (ekstern lenke)
- Mørch, Kristine; Hanevik, Kurt; Rørtveit, Guri et al. (2009). High rate of fatigue and abdominal symptoms 2 years after an outbreak of giardiasis. (ekstern lenke)
- Mørch, Kristine; Hanevik, Kurt; Rørtveit, Guri et al. (2009). Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. (ekstern lenke)
- Hanevik, Kurt; Mørch, Kristine; Eide, Geir Egil et al. (2008). Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: A randomized open clinical trial. (ekstern lenke)
- Mørch, Kristine; Hanevik, Kurt; Robertson, Lucy J. et al. (2008). Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. (ekstern lenke)
- Strand, Elisabeth Astrup; Robertson, Lucy J.; Hanevik, Kurt et al. (2008). Sensitivity of a Giardia antigen test in persistent giardiasis following an extensive outbreak. (ekstern lenke)
- Lagging, Martin; Langeland, Nina; Pedersen, Court et al. (2008). Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection. (ekstern lenke)
Doktorgradsavhandling
Short communication
Leserinnlegg
- Robertson, Lucy; Tysnes, Kristoffer; Hanevik, Kurt et al. (2015). Hund som Giardia-kilde i Bergen i 2004 - barking up the wrong tree?. (ekstern lenke)
- Lagging, Martin; Alsiö, Åsa; Langeland, Nina et al. (2011). Early determination of Hepatitis C virus RNA may help to decide the duration of therapy for chronic Hepatitis C virus genotype 2/3 infection. (ekstern lenke)
- Lagging, Martin; Langeland, Nina; Pedersen, Court et al. (2008). Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection. (ekstern lenke)
Sammendrag/abstract
- Rembeck, Karolina; Lindh, Magnus; Pedersen, Court et al. (2012). Impact of Inosine Triphosphatase (ITPA) Gene Variants on Anemia, Ribavirin Concentrations, and Outcome During Therapy for HCV Genotype 2/3. (ekstern lenke)
- Ydreborg, Magdalena; Lagging, Martin; Norkrans, Gunnar P. et al. (2012). A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis. (ekstern lenke)
- Rembeck, Karolina; Alsio, Asa; Christensen, Peer B. et al. (2011). Impact of obesity on the bioavailability of peginterferon-alpha 2A and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3. (ekstern lenke)
- Alsio, Asa; Langeland, Nina; Pedersen, Court et al. (2010). IMPORTANCE OF HCV CORE ANTIGEN BELOW 0.2 PG/ML DAY 3 IN SHORT-TERM PEG-INTERFERON THERAPY FOR CHRONIC GENOTYPE2/3 INFECTION. (ekstern lenke)
- Leutscher, Peter Derek Christian; Buhl, Mads Rauning; Lagging, Martin et al. (2009). EVALUATION OF THE ROUTINE MEDICAL INTERVIEW TO IDENTIFY HEPATITIS C PATIENTS DEVELOPING MAJOR DEPRESSION DURING PEGINTERFERON ALFA-2A PLUS RIBAVIRIN TREATMENT USING THE MAJOR DEPRESSION INVENTORY. (ekstern lenke)
- Westin, Johan; Lagging, Martin; Pedersen, Carsten et al. (2008). Twelve weeks of treatment is insufficient for HCV genotype 2 and 3 infected patients with steatosis. (ekstern lenke)
- Christensen, Peer B.; Alsiö, Åsa; Buhl, Mads Rauning et al. (2008). Ribavirin concentration at week four is an independend predictor for sustained virological response after treatment of hepatitis C genotype 2/3 (NORDynamic trial). (ekstern lenke)
- Lagging, Martin; Pedersen, Court; Buhl, Mads Rauning et al. (2007). Peginterferon alfa-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2/3: The nordynamic trial. (ekstern lenke)
- Lagging, Martin; Pedersen, Carsten; Buhl, Mads Rauning et al. (2007). Comparison of peginterferon alpha-2a and ribavirin for 12 or 24 weeks in patients with HCV genotype 2/3: The nordynamic trial. (ekstern lenke)